Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 23164713)

1.

Enantioselective synthesis of derivatives and structure-activity relationship study in the development of NA255 as a novel host-targeting anti-HCV agent.

Kawasaki K, Masubuchi M, Hayase T, Komiyama S, Watanabe F, Fukuda H, Murata T, Matsubara Y, Koyama K, Shindoh H, Sakamoto H, Okamato K, Ohta A, Katsume A, Aoki M, Aoki Y, Shimma N, Sudoh M, Tsukuda T.

Bioorg Med Chem Lett. 2013 Jan 1;23(1):336-9. doi: 10.1016/j.bmcl.2012.10.083. Epub 2012 Oct 30.

PMID:
23164713
2.

A novel class of geldanamycin derivatives as HCV replication inhibitors targeting on Hsp90: synthesis, structure-activity relationships and anti-HCV activity in GS4.3 replicon cells.

Shan GZ, Peng ZG, Li YH, Li D, Li YP, Meng S, Gao LY, Jiang JD, Li ZR.

J Antibiot (Tokyo). 2011 Feb;64(2):177-82. doi: 10.1038/ja.2010.161. Epub 2010 Dec 22.

PMID:
21179047
3.

Host sphingolipid biosynthesis as a target for hepatitis C virus therapy.

Sakamoto H, Okamoto K, Aoki M, Kato H, Katsume A, Ohta A, Tsukuda T, Shimma N, Aoki Y, Arisawa M, Kohara M, Sudoh M.

Nat Chem Biol. 2005 Nov;1(6):333-7. Epub 2005 Oct 16.

PMID:
16408072
4.

Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors.

Kang IJ, Wang LW, Hsu SJ, Lee CC, Lee YC, Wu YS, Yueh A, Wang JC, Hsu TA, Chao YS, Chern JH.

Bioorg Med Chem Lett. 2009 Nov 1;19(21):6063-8. doi: 10.1016/j.bmcl.2009.09.037. Epub 2009 Sep 17.

PMID:
19796940
5.

Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivatives.

Krueger AC, Madigan DL, Beno DW, Betebenner DA, Carrick R, Green BE, He W, Liu D, Maring CJ, McDaniel KF, Mo H, Molla A, Motter CE, Pilot-Matias TJ, Tufano MD, Kempf DJ.

Bioorg Med Chem Lett. 2012 Mar 15;22(6):2212-5. doi: 10.1016/j.bmcl.2012.01.096. Epub 2012 Feb 2.

PMID:
22342631
6.

Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors.

Kang IJ, Wang LW, Yeh TK, Lee CC, Lee YC, Hsu SJ, Wu YS, Wang JC, Chao YS, Yueh A, Chern JH.

Bioorg Med Chem. 2010 Sep 1;18(17):6414-21. doi: 10.1016/j.bmc.2010.07.002. Epub 2010 Jul 8.

PMID:
20675142
7.

Synthesis and anti-HCV activity of N9,5'-cyclo-3-(beta-D-ribofuranosyl)-8-azapurin-2-one derivatives.

Hassan AE, Wang P, McBrayer T, Tharnish P, Stuyver L, Otto MJ, Watanabe KA, Schinazi RF.

Nucleosides Nucleotides Nucleic Acids. 2005;24(10-12):1531-42.

PMID:
16438033
8.

Synthesis and evaluation of novel potent HCV NS5A inhibitors.

Zhang H, Zhou L, Amblard F, Shi J, Bobeck DR, Tao S, McBrayer TR, Tharnish PM, Whitaker T, Coats SJ, Schinazi RF.

Bioorg Med Chem Lett. 2012 Jul 15;22(14):4864-8. doi: 10.1016/j.bmcl.2012.05.039. Epub 2012 May 24.

9.

Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication.

Stankiewicz-Drogoń A, Dörner B, Erker T, Boguszewska-Chachulska AM.

J Med Chem. 2010 Apr 22;53(8):3117-26. doi: 10.1021/jm901741p.

PMID:
20337460
10.

First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virus.

Perrone P, Daverio F, Valente R, Rajyaguru S, Martin JA, Lévêque V, Le Pogam S, Najera I, Klumpp K, Smith DB, McGuigan C.

J Med Chem. 2007 Nov 1;50(22):5463-70. Epub 2007 Oct 3.

PMID:
17914786
11.

Synthesis and hepatitis C antiviral activity of 1-aminobenzyl-1H-indazole-3-carboxamide analogues.

Shi JJ, Ji FH, He PL, Yang YX, Tang W, Zuo JP, Li YC.

ChemMedChem. 2013 May;8(5):722-5. doi: 10.1002/cmdc.201300083. Epub 2013 Mar 19.

PMID:
23512654
12.

Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl purine nucleosides as inhibitors of hepatitis C virus RNA replication.

Clark JL, Mason JC, Hollecker L, Stuyver LJ, Tharnish PM, McBrayer TR, Otto MJ, Furman PA, Schinazi RF, Watanabe KA.

Bioorg Med Chem Lett. 2006 Mar 15;16(6):1712-5. Epub 2005 Dec 20.

PMID:
16368235
13.

The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.

Smith DB, Kalayanov G, Sund C, Winqvist A, Pinho P, Maltseva T, Morisson V, Leveque V, Rajyaguru S, Le Pogam S, Najera I, Benkestock K, Zhou XX, Maag H, Cammack N, Martin JA, Swallow S, Johansson NG, Klumpp K, Smith M.

J Med Chem. 2009 Jan 8;52(1):219-23. doi: 10.1021/jm800981y.

PMID:
19055482
14.

5'-O-masked 2'-deoxyadenosine analogues as lead compounds for hepatitis C virus (HCV) therapeutic agents.

Ikejiri M, Ohshima T, Kato K, Toyama M, Murata T, Shimotohno K, Maruyama T.

Bioorg Med Chem. 2007 Nov 15;15(22):6882-92. Epub 2007 Aug 22.

PMID:
17766124
15.

High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.

Hao W, Duggal R.

Methods Mol Biol. 2009;510:243-50. doi: 10.1007/978-1-59745-394-3_18.

PMID:
19009266
16.

Synthesis of 9-(2-beta-C-methyl-beta-d-ribofuranosyl)-6-substituted purine derivatives as inhibitors of HCV RNA replication.

Ding Y, Girardet JL, Hong Z, Lai VC, An H, Koh YH, Shaw SZ, Zhong W.

Bioorg Med Chem Lett. 2005 Feb 1;15(3):709-13.

PMID:
15664842
17.

Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics.

Obeid S, Printsevskaya SS, Olsufyeva EN, Dallmeier K, Durantel D, Zoulim F, Preobrazhenskaya MN, Neyts J, Paeshuyse J.

J Antimicrob Chemother. 2011 Jun;66(6):1287-94. doi: 10.1093/jac/dkr104. Epub 2011 Mar 24.

18.

Discovery of a β-d-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus.

Sofia MJ, Bao D, Chang W, Du J, Nagarathnam D, Rachakonda S, Reddy PG, Ross BS, Wang P, Zhang HR, Bansal S, Espiritu C, Keilman M, Lam AM, Steuer HM, Niu C, Otto MJ, Furman PA.

J Med Chem. 2010 Oct 14;53(19):7202-18. doi: 10.1021/jm100863x.

PMID:
20845908
19.

Synthesis of N6-substituted 9-[3-(phosphonomethoxy)propyl]adenine derivatives as possible antiviral agents.

El-Kattan Y, Lin TH, Wu M, Kumar VS, Kotian PL, Ghosh A, Cheng X, Bantia S, Babu YS, Chand P.

Nucleosides Nucleotides Nucleic Acids. 2005;24(10-12):1597-611.

PMID:
16438037
20.

Anti-hepatitis C virus activity of novel beta-d-2'-C-methyl-4'-azido pyrimidine nucleoside phosphoramidate prodrugs.

Rondla R, Coats SJ, McBrayer TR, Grier J, Johns M, Tharnish PM, Whitaker T, Zhou L, Schinazi RF.

Antivir Chem Chemother. 2009 Oct 19;20(2):99-106. doi: 10.3851/1400.

PMID:
19843980
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk